NextGen Biomed 2026
QEII Centre, London, UK
Immunotherapy & Immuno-oncology
PART OF NEXTGEN BIOMED 2026
24 - 25 March 2026 | QEII Centre, London, UK
A carefully curated event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of novel immunotherapies; advances in cellular, antibody and combination therapy development as well as personalised cancer therapy treatments.
Hear from past attendees of the Biologics 2024 conference
Gain invaluable insights into advancing the discovery & development of immunotherapies to treat cancer & autoimmune diseases. Aligned with current industry trends, the 2026 programme will provide exclusive insights into cell-based therapeutics approaches, cytokine therapies and tolerization immunotherapies
Unlock the power of multi-omics approaches in immunotherapy. Thought-leaders will be discussing the utilization of spatial technologies in immunotherapy research, single cell sequencing & digital pathology for immune-oncology
Be at the forefront of nextgen targets & novel therapeutic strategies innovations. Hear about advancements in the discovery of best-in-class therapeutic antibodies, biomarker discovery & validation and the latest technological approaches
Take a deep dive into using translational models in immuno-oncology. Gain invaluable insights into in vivo and in vitro approaches, humanized & 3D mouse models and the role of the tumour microenvironment in ensuring clinical success
leading pharma, biotech, regulatory & academic delegates
2026 Agenda at a Glance
Immunotherapy & Immuno-oncology
EVENT KICK OFF DAY - 23 MARCH
Track 4: Cancer Vaccines & Personalised Cancer Therapies
DAY ONE - 24 MARCH
Track 8: Discovery & Development Of Therapies For Cancer & Autoimmune Diseases
Track 9: Clinical Insights in Immuno-Oncology: Biomarkers, Pharmacokinetics & Safety Monitoring
Track 10: Next-Gen Targets & Therapeutic Strategies: Identification, Validation & Emerging Platforms
DAY TWO - 25 MARCH
Track 8: Optimising Clinical Development: Efficacy, Safety & Combination Strategies
Track 9: Multi-Omics Approaches in Immunotherapy
Track 10: Translational Models in Immuno-Oncology: In Vitro & In Vivo Approaches
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.